Offstream
news

Pfizer and its German partner BioNTech begin a clinical trial to test the safety and immune response of their Omicron-specific COVID-19 vaccine for adults under the age of 55 years.
2022-01-25

The Medicines and Healthcare products Regulatory Agency approves the use of Pfizer's anti-viral oral drug Paxlovid for high-risk patients.
2021-12-31

The Pentagon announces that COVID-19 vaccinations will be mandatory for the U.S. military after the FDA approved the vaccine developed by Pfizer and BioNTech.
2021-08-25

A study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant, while the AstraZeneca–Oxford vaccine is 92% effective.
2021-06-14

Governor Charlie Baker receives his first dose of the Pfizer vaccine.
2021-04-6

Supreme Leader Ali Khamenei calls for a ban on the American Pfizer and British AstraZeneca vaccines.
2021-01-8

The Indian government announces that the country will speed up their reviews of vaccines developed by Pfizer and AstraZeneca.
2020-12-7

Mexican Foreign Minister Marcelo Ebrard announces the country has signed agreements with AstraZeneca for 77.4 million, COVAX for 51.57 million, CanSino Biologics for 35 million, and Pfizer for 34.4 million vaccine doses, respectively. The vaccines by Pfizer, AstraZeneca, and the COVAX plan require two doses, whereas the CanSino product requires one dose.
2020-10-13

AstraZeneca rejects the latest, and likely the last, takeover price from Pfizer, close to 70 billion pounds or US$118 billion.
2014-05-19